Table 2

Procedural characteristics and outcome for overall GA and non-GA patients

All, n=2243GA, n=1816Non-GA, n=427P values
Valve type
 Edwards Sapien1365 (60.9)1125 (61.9)240 (56.2)0.032
 Medtronic CoreValve878 (39.1)691 (38.1)187 (43.8)
Delivery approach
 Percutaneous1792 (79.9)1385 (76.3)407 (95.3)< 0.001
 Surgical cut down451 (20.1)431 (23.7)20 (4.7)
Procedural imaging
 Transoesophageal echocardiography1729 (77.1)1676 (92.3)53 (12.4)< 0.001
 None or other514 (22.9)140 (7.7)374 (87.6)
Predeployment balloon valvuloplasty1365 (60.9)1139 (62.8)226 (52.9)<0.001
Postdeployment balloon dilatation304 (13.8)251 (14.1)53 (12.8)0.528
Successful valve deployment2154 (96.9)1750 (97.2)404 (95.7)0.104
Aortic regurgitation at the end of the procedure, any degree1181 (53.9)966 (54.4)215 (51.7)0.326
Aortic regurgitation at the end of the procedure, more than mild128 (5.8)99 (5.6)29 (7.0)0.295
Conversion to full sternotomy31 (1.4)28 (1.5)3 (0.7)0.249
Acute kidney injury within 7 days of the procedure137 (6.2)107 (6.0)30 (7.4)0.307
New dialysis before discharge42 (1.9)36 (2.0)6 (1.5)0.554
Tamponade during or after procedure53 (2.4)43 (2.4)10 (2.4)>0.999
Cerebrovascular attack up to discharge53 (2.38)42 (2.3)11 (2.6)0.722
Major or life-threatening bleeding103 (4.7)58 (4.4)18 (4.4)0.897
Vascular access site complications238 (10.7)198(11)40 (9.5)0.430
Procedure time (min)129.1±59.9131±60.0121±60.00.002
Length of stay in hospital (days)7.6±12.48.0±13.55.7±5.5<0.001
  • Values are mean±SD or n (%).

  • GA, general anaesthesia.